{"id":71595,"date":"2024-01-11T06:24:05","date_gmt":"2024-01-11T14:24:05","guid":{"rendered":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/2024\/01\/11\/tilray-sees-cannabis-rescheduling-as-gateway-to-us-medical-market\/"},"modified":"2024-01-11T07:45:37","modified_gmt":"2024-01-11T15:45:37","slug":"tilray-sees-cannabis-rescheduling-as-gateway-to-us-medical-market","status":"publish","type":"post","link":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/2024\/01\/11\/tilray-sees-cannabis-rescheduling-as-gateway-to-us-medical-market\/","title":{"rendered":"Tilray Sees Cannabis Rescheduling as Gateway to US Medical Market"},"content":{"rendered":"<p> <span class=\"field field--name-title field--type-string field--label-hidden\">Tilray Sees Cannabis Rescheduling as Gateway to US Medical Market<\/span><\/p>\n<figure class=\"field field--name-field-image-media field--type-entity-reference field--label-hidden field__items\">\n<div class=\"media-image view-mode-teaser-landscape\">\n<figure class=\"field field--name-field-media-image field--type-image field--label-visually_hidden field__items\">\n<div class=\"field__label visually-hidden\">Image<\/div>\n<p>              <img src=\"https:\/\/cannabiscultivatornews.com\/home\/wp-content\/uploads\/2024\/01\/Tilray20Sees20Cannabis20Rescheduling20as20Gateway20to20US20Medical20Market.jpg\" width=\"500\" height=\"300\" alt=\"Tilray Sees Cannabis Rescheduling as Gateway to US Medical Market\" loading=\"lazy\" class=\"img-fluid\" \/><\/figure>\n<\/div>\n<\/figure>\n<p><span class=\"field field--name-uid field--type-entity-reference field--label-hidden\"><a title=\"View user profile.\" href=\"https:\/\/420intel.com\/users\/cannabis-news\" class=\"username\">Cannabis News<\/a><\/span><br \/>\n<span class=\"field field--name-created field--type-created field--label-hidden\">January 11, 2024<\/span>\n    <\/p>\n<div class=\"clearfix text-formatted field field--name-body field--type-text-with-summary field--label-hidden field__items\">\n<p>Tilray Eyes Quick Entry into US Medical Cannabis Market if Federal Reclassification Occurs. Tilray Brands believes it can get into the medical marijuana business in the U.S. pretty quickly if the Biden administration reclassifies cannabis as a Schedule 3 drug sometime this year, CEO Irwin Simon<\/p>\n<\/p><\/div>\n<ul class=\"display-list inline-list field field--name-field-tags field--type-entity-reference field--label-hidden field__items\">\n<li class=\"field__item\">\n        <a href=\"https:\/\/420intel.com\/articles\/cannabis-technology-news\">Cannabis Technology News<\/a>\n            <\/li>\n<li class=\"field__item\">\n        <a href=\"https:\/\/420intel.com\/articles\/marijuana-business-news\">Marijuana Business News<\/a>\n            <\/li>\n<li class=\"field__item\">\n        <a href=\"https:\/\/420intel.com\/articles\/cannabis-jobs\">Cannabis Jobs<\/a>\n            <\/li>\n<\/ul>\n<div class=\"field field--name-field-source field--type-link field--label-hidden field__items\">\n<div class=\"field__item\">\n        <a href=\"https:\/\/www.barrons.com\/livecoverage\/stock-market-today-100124\/card\/tilray-sees-cannabis-rescheduling-as-gateway-to-u-s-medical-market-k8ic9cFbTqyqRvM8lqt5\">Barron&#8217;s<\/a>\n            <\/div>\n<\/p><\/div>\n<p>&#013;<br \/>\n&#013;<br \/>\nRead More: <a href=\"https:\/\/420intel.com\/articles\/2024\/01\/11\/tilray-sees-cannabis-rescheduling-gateway-us-medical-market\" target=\"_blank\" rel=\"noopener\">Tilray Sees Cannabis Rescheduling as Gateway to US Medical Market<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Tilray Sees Cannabis Rescheduling as Gateway to US Medical Market Image Cannabis News January 11, 2024 Tilray Eyes Quick Entry into US Medical Cannabis Market if Federal Reclassification Occurs. Tilray Brands believes it can get into the medical marijuana business in the U.S. pretty quickly if the Biden administration reclassifies<span class=\"more-link\"><a href=\"https:\/\/cannabiscultivatornews.com\/home\/index.php\/2024\/01\/11\/tilray-sees-cannabis-rescheduling-as-gateway-to-us-medical-market\/\">Continue Reading<\/a><\/span><\/p>\n","protected":false},"author":535,"featured_media":0,"comment_status":"false","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/71595"}],"collection":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/users\/535"}],"replies":[{"embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/comments?post=71595"}],"version-history":[{"count":1,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/71595\/revisions"}],"predecessor-version":[{"id":71596,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/posts\/71595\/revisions\/71596"}],"wp:attachment":[{"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/media?parent=71595"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/categories?post=71595"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cannabiscultivatornews.com\/home\/index.php\/wp-json\/wp\/v2\/tags?post=71595"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}